Vasodilatation with felodipine in chronic asymptomatic aortic regurgitation

American Heart Journal

Volumn 139, Issue 4, 2000, Pages 667-674

  Søndergaard, Lars ^a,e   Aldershvile, Jan ^b   Hildebrandt, Per ^c   Kelbæk, Henning ^b   Ståhlberg, Freddy ^d   Thomsen, Carsten ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c FREDERIKSBERG HOSPITAL   (Denmark)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; FELODIPINE; PLACEBO;

AORTA VALVE DISEASE; AORTA VALVE REGURGITATION; ARTICLE; BLOOD FLOW VELOCITY; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HEMODYNAMIC PARAMETERS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034074926     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90046-2     Document Type: Article

References (42)

1. 1. Bonow RO, Rosing DR, McIntosh CL, et al. The natural history of asymptomatic patients with aortic regurgitation and normal left ventricular function. Circulation 1983;68:509-17.
2. 2. Bolen JL, Alderman EL. Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation. Circulation 1976;53:879-83.
3. 3. Miller RR, Vismara LA, DeMaria AN, et al. Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume. Am J Cardiol 1976; 38:564-7.
4. 4. Sasayama S, Ohyagi A, Lee JD, et al. Effect of the vasodilator therapy in regurgitant valvular disease. Jpn Circ J 1982;46;433-41.
5. 5. Hockings BEF, Cope GD, Clarke GM, et al. Comparison of vasodilator drug prazosin with digoxin in aortic regurgitation. Br Heart J 1980;43:550-5.
6. 6. Jebavy P, Koudelková E, Henzlová M. Unloading effects of prazosin in patients with chronic aortic regurgitation. Am Heart J 1983; 105:567-74.
7. 7. Greenberg BH, DeMots H, Murphy E, et al. Beneficial effects of hydralazine on rest and exercise hemodynamics in patients with chronic severe aortic insufficiency. Circulation 1980;62:49-55.
8. 8. Greenberg BH, DeMots H, Murphy E, et al. Mechanism for improved cardiac performance with arteriolar dilators in aortic insufficiency. Circulation 1981;63:263-8.
9. 9. Reske SN, Heck I, Kropp J, et al. Captopril mediated decrease of aortic regurgitation. Br Heart J 1985;54:415-9.
10. 10. Klepzig H Jr, Mildenberger D, Baum R, et al. Wirkung von Captopril bei chronischer Aortainsuffizienz. Z Kardiol 1986;75:283-90.
11. 11. Röthlisberger C, Sareli P, Wisenbaugh T. Comparison of single-dose nifedipine and captopril for chronic severe aortic regurgitation. Am J Cardiol 1993;71:799-804.
12. 12. Fioretti P, Benussi B, Scardi S, et al. Afterload reduction with nifedipine in aortic insufficiency. Am J Cardiol 1982;49:1728-32.
13. 13. Fioretti P, Benussi B, Klugmann S, et al. Acute hemodynamic effects of nifedipine at rest and during stress in severe aortic incompetence. Eur Heart J 1983;4:110-6.
14. 14. Shen WF, Roubin GS, Hirasawa K, et al. Noninvasive assessment of acute effects of nifedipine on rest and exercise hemodynamics and cardiac function in patients with aortic regurgitation. J Am Coll Cardiol 1984;4:902-7.
15. 15. Gentile F, Ornaghi M, Esposti D, et al. Hemodynamic effects of nifedipine in patients with asymptomatic aortic regurgitation: evaluation by Doppler echocardiography. Acta Cardiol 1993;48:495-506.
16. 16. Jensen T, Kornerup HJ, Lederballe O, et al. Treatment with hydralazine in mild to moderate mitral or aortic incompetence. Eur Heart J 1983; 4:306-12.
17. 17. Kleaveland JP, Reichek N, McCarthy DM, et al. Effects of six-month afterload reduction therapy with hydralazine in chronic aortic regurgitation. Am J Cardiol 1986;57:1109-16.
18. 18. Greenberg B, Massie B, Bristow JD, et al. Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placed-controlled clinical trial. Circulation 1988;78:92-103.
19. 19. Dumesnil JG, Tran K, Dagenais GR. Beneficial long-term effects of hydralazine in aortic regurgitation. Arch Intern Med 1990; 150:757-60.
20. 20. Lin M, Chiang HT, Lin SL, et al. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy. J Am Coll Cardiol 1994;24:1046-53.
21. 21. Heck I, Schmidt J, Mattern H, et al. Reduktion der regurgitation bei aorten-und mitralinsuffizienz durch captopril im akut-und langzeitversuch. Schweiz Med Wochenschr 1985;115:1615-8.
22. 22. Wisenbaugh T, Sinovich V, Dullabh A, et al. Six months pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation. J Heart Valve Dis 1994;3:197-204.
23. 23. Schön HR, Dorn R, Barthel P, et al. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation. J Heart Valve Dis 1994;3:500-9.
24. 24. Globits S, Blake L, Bourne M, et al. Assessment of hemodynamic effects of angiotensin-converting enzyme inhibitor therapy in chronic aortic regurgitation by using velocity-encoded cine magnetic resonance imaging. Am Heart J 1996;131:289-93.
25. 25. Weyer C, Mohr-Kahaly S, Erbel R, et al. Verlaufsbeobachtung von Patienten mit chronischer Aortenklappeninsuffizienz unter ACE-Hemmer-Therapie. Z Kardiol 1997;86:1010-6.
26. 26. Scognamiglio R, Fasoli G, Ponchia A, et al. Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol 1990;16:424-9.
27. 27. Kelbæk H, Aldershvile J, Svendsen JH, et al. Combined first pass and equilibrium radionuclide cardiographic determination of stroke volume for quantitation of valvular regurgitation. J Am Coll Cardiol 1988;11:769-73.
28. 28. Søndergaard L, Lindvig K, Hildebrandt P, et al. Quantification of aortic regurgitation by magnetic resonance velocity mapping. Am Heart J 1993;125:1081-90.
29. 29. Møgelvang J, Thomsen C, Mehlsen J, et al. Evaluation of left ventricular volumes measured by magnetic resonance imaging. Eur Heart J 1986;7:1016-21.
30. 30. Møgelvang J, Thomsen C, Horn T, et al. Determination of left ventricular myocardial volume (mass) by magnetic resonance imaging. Am J Noninvas Cardiol 1987;1:231-6.
31. 31. Carabello BA, Crawford FA. Valvular heart disease. N Engl J Med 1997;337:32-41.
32. 32. Klodas E, Enriquez-Sarano M, Tajik AJ, et al. Optimizing timing of surgical correction in patients with severe aortic regurgitation: role of symptoms. J Am Coll Cardiol 1997;3:746-52.
33. 33. Sechtem U, Pflugfelder PW, White RD, et al. Cine MR imaging: potential for the evaluation of cardiovascular function. Am J Roentgenol 1987;148:239-46.
34. 34. Ståhlberg F, Thomsen C, Søndergaard, et al. Pulse sequence design for MR velocity mapping of complex flow: notes on the necessity of low echo times. Mag Reson Imaging 1994;12:1255-62.
35. 35. Chatzimavroudis GP, Oshinski JN, Franch RH, et al. Quantification of aortic regurgitation volume with magnetic resonance phase velocity mapping: a clinical investigation of the importance of imaging slice location. J Heart Valve Dis 1998;7:94-101.
36. 36. Nayler GL, Firmin DN, Longmore DB. Blood flow imaging by cine magnetic resonance. J Comput Assist Tomogr 1986;10:715-22.
37. 37. Collé R. Accuracy requires precision: a comment on understanding and using statistics in nuclear medicine [letter]. J Nucl Med 1980;21:290-2.
38. 38. Ludbrook PA, Tiefenbrunn AJ, Reed FR, et al. Acute hemodynamic responses to sublingual nifedipine: dependence on left ventricular function. Circulation 1982;65:489-98.
39. 39. Dulce MC, Mostbeck GH, O'Sullivan M, et al. Severity of aortic regurgitation: interstudy reproducibility of measurements with velocity-encoded cine MR imaging. Radiology 1992;185:235-40.
40. 40. Honda N, Machida K, Hashimoto M, et al. Aortic regurgitation: quantification with MR imaging velocity mapping. Radiology 1993; 186:189-94.
41. 41. Engels G, Reynen K, Müller E, et al. Quantifizierung der Aortenklappeninsuffizienz in der Magnetresonanztomographie. Z Kardiol 1993;82:345-51.
42. 42. Scognamiglio R, Rahimtoola SH, Fasoli G, et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994;331:689-94.